News FDA turns down 'national priority' drug from Disc Medicine One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned down by the regulator.
News Disc maps out US filing for porphyria drug bitopertin Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.
Oncology Sponsored The Compound Effect: Real-World Evidence for the Impact of C... In a new report, Medscape Medical Affairs explores the question of whether a coordinated programme drives more real-world behaviour change.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.